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Summary
Objective: Matrix metalloproteinase-13 (MMP-13) is an extracellular MMP that cleaves type II collagen, the major protein component of car-
tilage, with high speciﬁcity and has been implicated in the pathology of osteoarthritis. The present study aimed to characterize the binding and
internalization kinetics of MMP-13 in normal rabbit chondrocytes and whether MMP-13 affected cell signalling.
Methods: Rabbit chondrocytes were used in [125I]-MMP-13 binding assays to investigate the MMP-13 binding kinetics and Western analysis
allowed for the assessment of intracellular signalling cascades.
Results: Rabbit chondrocytes were found to express the cartilage-speciﬁc genes aggrecan and type II collagen throughout their in vitro culture
period. Appreciable speciﬁc cell-association of [125I]-MMP-13 was detected after 10 min of exposure to the ligand and equilibrium was ob-
tained after 2 h. Binding of [125I]-MMP-13 to chondrocytes was speciﬁc and approached saturation at 75 nM. Internalization of MMP-13
was evident after 20 min, reached a maximum at 30 min and had returned to baseline by 90 min. Addition of receptor-associated protein
(RAP) inhibited the internalization of MMP-13 indicating a likely role for low-density lipoprotein receptor-related protein-1 (LRP1) in this pro-
cess. Interestingly the presence of MMP-13 induced phosphorylation of the extracellular signal-regulated kinase 1/2 (ERK1/2) protein showing
that there is initiation of a signalling process in response to MMP-13 being bound and internalized by rabbit chondrocytes. However, this ac-
tivation does not involve the MMP-13 internalization receptor LRP1.
Conclusion: These studies demonstrate and characterize the MMP-13 binding and internalization system in rabbit chondrocytes and indicate
that MMP-13 may regulate the phenotype of the chondrocytes through this receptor system.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The maintenance of articular cartilage requires a balance
between catabolism and synthesis of the extracellular carti-
lage matrix, dual functions performed by a single cell, the
chondrocyte. Osteoarthritis (OA), the most common arthri-
tis, is characterized radiologically as narrowing of the joint
space due to loss of articular cartilage1. Evidence suggests
that disruption of the normal balance of cartilage synthesis
and degradation is a pathophysiological catalyst for this
multifactorial disease2. Ultimately the erosion of type II col-
lagen and aggrecan, the principal structural components of
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to irreversible cartilage destruction in OA4,5.
Matrix metalloproteinases (MMPs) are enzymes involved
in the remodelling of the extracellular matrix during develop-
ment, wound healing and disease (reviewed in Ref. 6). This
proteolytic family of enzymes is divided into four groups:
collagenases, gelatinases, stromelysins and membrane
metalloproteinases. MMP-13 (collagenase-3) acts at physi-
ological pH to degrade ﬁbrillar collagens (types I, II and III)
and aggrecan7. Cleavage of collagen by collagenase MMPs
occurs at an internal helical site to produce 1/4 and 3/4 frag-
ments8 and at an aminotelopeptide site, which is thought to
initiate ﬁbrillar depolymerization9,10.
MMP-13 is secreted from cells as an inactive proenzyme
and is activated via autocatalysis, by other MMPs and pro-
teases (reviewed in Ref. 11). The activated MMP-13 then
acts on the local extracellular structures prior to proteolytic
inactivation, inhibition by tissue inhibitors of metalloprotei-
nases (TIMPs)12,13 or receptor-mediated endocytosis and
degradation14. Our laboratory has previously described
a speciﬁc endocytotic receptor for MMP-13 on osteoblas-
tic14 and ﬁbroblastic cells15. The internalization mechanism
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tors. An unknown speciﬁc MMP-13 cell surface receptor is
required for binding the MMP-13 protein to the cell surface
and the low-density lipoprotein receptor-related protein-1
(LRP1) is involved in the internalization of MMP-13. Re-
cently we have reported that normal human chondrocytes
and synoviocytes and those from OA patients are also capa-
ble of internalizing MMP-1316. The human OA chondrocytes
had reduced ability to bind MMP-13 and thus were conse-
quently impaired in their ability to internalize and degrade
the enzyme16. MMP-13 is overexpressed by chondrocytes
in OA cartilage17e19 and type II collagen is the preferred
substrate for MMP-1320. The use of synthetic collagenase
inhibitors has provided evidence that MMP-13 is the major
collagenase involved in the chondrocyte mediated cleavage
of type II collagen21. In addition the targeted expression of
constitutively active MMP-13 generates an OA-like pathol-
ogy in transgenic mice22. Despite the known involvement
of MMP-13 in OA and these interesting and potentially clin-
ically important observations of the MMP-13 internalization
mechanism in OA chondrocytes a comprehensive assess-
ment of the binding and internalization mechanism has not
been performed on normal chondrocytes, due to the difﬁ-
culty of obtaining them in abundance.
In addition to the actions that MMPs have on molecules of
the extracellular matrix, the fact that they are able to bind to
cell surface receptors suggests that these molecules may
also be able to signal into the cell thus directing cellular
function. The known component of the osteoblast MMP-
13 internalization complex, LRP1, is a promiscuous recep-
tor able to interact and bind many proteins. Most recently
LRP1 has been shown to regulate intracellular signalling
pathways and in doing so inﬂuence pathological disease23.
Our laboratory has previously documented a process
whereby osteoblastic cells remove MMP-13 from the sur-
rounding milieu by binding the enzyme to a speciﬁc recep-
tor. The enzyme is then internalized and degraded
through the actions of the endocytotic receptor, the low-
density LRP1. Furthermore we have also identiﬁed this pro-
cess of MMP-13 internalization in human chondrocytes and
found that it is signiﬁcantly reduced in human chondrocytes
from patients with OA. In these present investigations we
have characterized the MMP-13 receptor-mediated inter-
nalization system in normal rabbit chondrocytes and also
identiﬁed that the presence of the exogenous MMP-13 pro-
tein is able to lead to activation of the extracellular signal-
regulated kinase 1/2 (ERK1/2) intracellular signalling
enzymes.
Materials and methods
MATERIALS
MMPs-2, -3, -8, and -9 were purchased from R&D Sys-
tems. Bovine collagen type II was obtained from Morwell
MD Biosciences Inc. Antibodies for ERK1/2 and phospho-
ERK1/2 were purchased from Santa Cruz (Santa Cruz,
CA) and the AKT and phospho-AKT antibodies came from
Cell Signalling (Beverley, MA). All other reagents unless
otherwise stated were purchased from SigmaeAldrich
(St Louis, MO).
CELL CULTURE
Rabbit chondrocytes were harvested as previously de-
scribed24 from the humerus and femur of New Zealandwhite rabbits by shaving off the articular cartilage. The
cartilage was incubated with agitation for 18e24 h in DMEM
(Invitrogen) containing 2 mg/ml of collagenase A (Roche
Diagnostic), 0.1 mg/ml hyaluronidase, and 0.15 mg/ml
DNase at 37(C in 5% CO2. Following an overnight incuba-
tion the cells were washed 2 in DMEM and seeded at
2 105 cells/cm2. Rabbit chondrocytes were cultured and
used in experiments for a maximum of three passages.
Mouse embryo ﬁbroblast (MEF1) cells were cultured and
maintained in DMEM with 10% foetal bovine serum (FBS)
as previously described15.
PRODUCTION OF RECOMBINANT PROTEINS
Recombinant mouse MMP-13 [which has 87% amino
acid sequence homology with human MMP-1325 and 85%
nucleotide homology with rabbit MMP-13] had previously
been subcloned into the pET30a expression plasmid (Stra-
tagene, La Jolla, CA) and transformed into BL21 Escheri-
chia coli16. Expression of recombinant protein was
induced with the addition of isopropyl b-D-thiogalactoside
(IPTG; 0.4 mM, Boehringer Mannheim) to a culture in log-
phase growth. After 4 h, bacteria were centrifuged, and
the pellet stored overnight at 70(C. The bacterial pellet
was then resuspended in 50 mM TriseHCl, 200 mM NaCl,
5 mM CaCl2, 1 mM PMSF, 1 protease inhibitors and
0.25 mg/ml lysozyme, incubated on ice for 30 min, freeze
thawed 3 and centrifuged for 30 min at 9000g at 4(C.
The pellet was resuspended in 20 mM TriseHCl pH 7.6,
6 M guanidine HCl, 1 mM PMSF and 1 protease inhibitors
using a Dounce homogenizer and solubilized by rocking at
room temperature for 30 min. The solution was then centri-
fuged and the supernatant collected. All subsequent steps
were performed at 4(C. Puriﬁcation of the protein was per-
formed using a HiTrap nickel column sequentially washed
with water and then wash buffer (20 mM TriseHCl pH 7.6
and 3 M guanidine HCl). The protein was then diluted 1:1
with 20 mM TriseHCl pH 7.6 and passed through the col-
umn. The column was washed with elution buffer 1
(20 mM TriseHCl pH 7.6, 3 M guanidine HCl and 20 mM im-
idazole) and eluted with elution buffer 2 (20 mM TriseHCl
pH 7.6, 3 M guanidine HCl and 500 mM imidazole) in
500 ml fractions. The protein-containing fractions were di-
luted 10-fold by drop wise addition with stirring into refolding
buffer (glycerol 20%, 50 mM TriseHCl pH 7.6, 200 mM
NaCl, 50 mM ZnSO4, 2.3 M Urea, 0.05% Brij, 2.5 mM oxi-
dized glutathione, 2.5 mM reduced glutathione) and then al-
lowed to incubate without stirring for 2 h at 4(C. The protein
was then dialysed in 1 L of dialysis buffer (50 mM TriseHCl
pH 7.6, 200 mM NaCl, 2 M urea) for 1.5 h and then in 3 L
overnight. Finally the protein was concentrated and immedi-
ately frozen at 70(C. Puriﬁed His-tagged MMP-13 is en-
zymatically active (as determined by gelatin zymography)
and has a molecular mass of 62 kDa compared to 58 kDa
native enzyme due to the presence of the 44 amino acid
residue N-terminal puriﬁcation tag. Puriﬁcation of the
GST-tagged receptor-associated protein (RAP) protein
was performed as previously described26.
RADIOIODINATION OF MMP-13
Puriﬁed recombinant mouse MMP-13 was labelled with
[125I] using the chloramine T method27. Brieﬂy, 25 mg of pu-
riﬁed enzyme, 1 mCi Na125I (Amersham) and 4 mg of chlora-
mine T were incubated for 10 min at room temperature in
enzyme buffer (50 mM TriseHCl, pH 7.5, 10 mM CaCl2).
The reaction was quenched by the sequential addition of
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220 ml elution buffer (enzyme buffer with 0.8 M NaCl). The
ﬁnal reaction mixture was then applied to an Econopac
DG desalting column (Biorad) and eluted sequentially
with 500 ml of elution buffer at 4(C. SDS-PAGE followed
by autoradiographic analysis of the eluted fragments
demonstrated that the [125I]-MMP-13 co-migrated with the
unlabelled puriﬁed MMP-13 protein. In addition >95% of
the [125I]-MMP-13 precipitated in 20% trichloracetic acid
and the speciﬁc activity ranged between 2 and 27 mCi/mg.
RT-PCR
Total RNA was isolated from monolayer cultures of pri-
mary rabbit chondrocytes and cells cultured following one,
two or three passages, using Tri-reagent (Sigma). RT-
PCR was performed on 1 mg of total RNA using the Super-
script One Step RT-PCR kit (Invitrogen). Oligonucleotides
able to amplify rabbit MMP-13 (sense: 50-CCT CCT GGA
CCA AAT TAT GGA GG-30, anti-sense: 50-AAC AGC TCT
GCA TCC ACC TGC CTG-30), Tm¼ 58(C, ampliﬁed
395 bp fragment; collagen I (sense: 50-CCC CAG CCA
CAA AGA GTA TAC A-30, antisense: 50-AGG TCC AGG
ACG ACC ATC TTC 30), Tm¼ 65(C, ampliﬁed 643 bp frag-
ment; collagen II (sense: 50-ATG GAA TTC CTG GAG CCA
AAG G-30, antisense; 50-AGG TCC AGG ACG ACC ATC
TTC-30), Tm¼ 62(C, ampliﬁed 529 bp fragment; aggrecan
(sense: 50-TGG CTG ATC TCA GGT A-30, antisense: 50-
TGT GTA GCG TAT GGC GTC GTA-30), Tm¼ 60(C, ampli-
ﬁed 442 bp fragment, and b-actin (sense: 50-GAC TAC CTC
ATG AAG ATC CTC-30, antisense: 50-AGG AAG GAG GGC
TGG AAC AG-30), Tm¼ 58(C, ampliﬁed 242 bp fragment,
were used to speciﬁcally amplify these genes. The products
were then analysed on a 2% agarose gel.
BINDING ASSAYS
Binding assays were performed on conﬂuent cells in
24 well (2.5 cm2) plates. Cells were incubated with the
indicated concentrations of [125I]-MMP-13 at 4(C for
the speciﬁed period of time. Non-speciﬁc binding and
binding competition analysis were performed by adding
100-fold excess of unlabelled protein to triplicate wells. After
binding the cells were rinsed 3 with cold DMEM, lysed with
1 M NaOH and assayed for radioactivity. Cell enumeration
was performed with a haemocytometer on replicate wells.
INTERNALIZATION AND DEGRADATION ASSAYS
After binding 5 nM per well of [125I]-MMP-13, as
described above, the cells were rinsed 3 with cold
DMEM. Warm (37(C) DMEM (250 ml) was added to the
wells and the cells were placed at 37(C for the indicated
time period to allow receptor-mediated endocytosis and
intracellular processing of the ligand. Following incubation
the cells were treated with 0.25% Pronase E for 10 min to
remove cell surface proteins. The cells were then centri-
fuged to separate the cell surface fraction (supernatant)
from the internalized fraction (pellet). In experiments mea-
suring MMP-13 degradation, media overlying the cells
were collected at the speciﬁed times following internaliza-
tion. These supernatants were incubated with 20% TCA in
ethanol (250 ml) and 2% BSA in Tris buffer (pH 7.5, 1 ml)
for 2 h on a rocking platform to precipitate intact proteins.
The mixture was then centrifuged and the radioactivity in
the supernatant (representing the non-precipitable de-
graded protein) was measured.IMMUNOBLOTTING EXPERIMENTS
Cells were seeded in 6-well culture plates and the follow-
ing day serum starved for 24 h. The cells were then incu-
bated with 50 nM MMP-13 for the indicated time, then
washed in room temperature PBS and lysed in lysis buffer
(20 mM TriseHCl pH 8.0, 2 mM EDTA pH 8.0, 10%
glycerol, 1% Triton-X100, 1 protease inhibitors (Roche
Diagnostic), 1 mM sodium vanadate and 50 mM b-
glycerophosphate). After lysis the cells were incubated on
ice for 20 min prior to microfuging for 5 min to remove cellu-
lar debris. A protein assay was then performed on the cell
lysate (BioRad) and 10 mg of protein was separated under
reducing conditions on a 10% SDS-PAGE gel. The proteins
were then transferred to PVDF and incubated in TBST
(20 mM TriseHCl pH 7.6, 137 mM NaCl and 0.1% Tween
20) with 5% non-fat milk and the indicated antibody over-
night at 4(C. Following washing the ﬁlters were incubated
in a 1:10,000 dilution of the appropriate horseradish perox-
idase-conjugated IgG and the signal detected using an ECL
plus kit (Amersham).
STATISTICAL ANALYSIS
Receptor kinetics were determined by non-linear regres-
sion using the GraphPad InPlot 4.0 program. Multi-group
mean values were compared using a one-way analysis of
variance (ANOVA) and values of P< 0.05 were considered
signiﬁcant.
Results
RABBIT CHONDROCYTES RETAIN THEIR CHONDROCYTIC
PHENOTYPE IN SHORT TERM CELL CULTURE
The growth of primary chondrocytes in culture is chal-
lenging and like many cell types these cells undergo a pro-
cess of dedifferentiation with sequential passaging. To
ensure the phenotypic integrity of the chondrocytes used
in this study the cells were assessed for the expression of
the cartilage-speciﬁc genes aggrecan and type II collagen
throughout the culture period (Fig. 1). The mRNA of the ex-
tracellular matrix protein aggrecan was expressed at con-
sistently high levels in primary cells as well as cells
passaged once, twice and three times, however, the ex-
pression of type II collagen, a speciﬁc marker of articular
cartilage, decreased with subsequent passage of the chon-
drocytes and was only present at very low levels after the
third passaging of the cells. Concurrently with the decline
in expression of type II collagen there was an increase in
the expression of type I collagen seen in the cells. The in-
appropriate synthesis of type I collagen by primary chondro-
cytes has been noted previously28. In addition the loss of
type II collagen expression in cultured chondrocytes has
also been reported28 and is indicative that the cells are un-
dergoing dedifferentiation. As a consequence of these data
only cells passaged once or twice were used in the subse-
quent studies. Interestingly the rabbit chondrocytes ex-
pressed consistent levels of MMP-13 mRNA throughout
the culture period.
BINDING OF MMP-13 TO RABBIT CHONDROCYTES WAS
SATURABLE AND SPECIFIC AND SUGGESTIVE THAT
THERE ARE SEVERAL RECEPTOR CLASSES PRESENT
To determine the amount of time required for the [125I]-
MMP-13 ligand to establish equilibrium, a time course of
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Fig. 1. Phenotyping cultured rabbit chondrocytes by RT-PCR. Total RNA was isolated from rabbit chondrocytes in primary culture or after pas-
sages 1, 2 or 3. RT-PCR was performed with 1 mg of total RNA and sense and anti-sense primers of the gene of interest. Thirty ampliﬁcation
cycles of standard PCR conditions were employed for all genes except collagen I where 40 cycles were used.binding was performed. Appreciable speciﬁc cell-associated
[125I]-MMP-13 was detected after a 10-min exposure of
rabbit chondrocytes to the ligand and equilibrium was
approached after 2 h [Fig. 2(A)]. Thus in all subsequent
binding experiments a 2-h incubation period was used.
Incubation of increasing concentrations of [125I]-MMP-13
with rabbit chondrocytes showed that the binding of MMP-
13 was speciﬁc and saturable [Fig. 2(B)] and suggested
that there are several receptor classes present. Non-linear
regression analysis by the GraphPad InPlot program indi-
cated a high afﬁnity binding site with a Kd of 12.7 nM and
a Bmax of 0.79 fmol/10
6 cells or w5000 receptors/cell. The
low afﬁnity site was calculated to have a Kd of 58.6 nM
and a Bmax of 4.12 fmol/10
6 cells or w25,000 receptors/
cell. The binding of [125I]-MMP-13 to rabbit chondrocytes
was competitive as increasing concentrations of cold
MMP-13 were able to compete off the hot ligand
[Fig. 2(C)]. A log transformation of these data [Fig. 2(C), in-
sert] shows that the competition curve decreases over more
than one log phase, which further suggests that MMP-13 is
binding to a multiple receptor system.
Receptor speciﬁcity for MMP-13 to the chondrocyte cell
surface was demonstrated in competition experiments
with a panel of extracellular matrix proteins. The rabbit
chondrocytes were incubated with 5 nM of [125I]-MMP-13
and 100-fold molar excess of the potential competitors.
Binding of [125I]-MMP-13 to rabbit chondrocytes was highly
speciﬁc, none of the proteins tested were able to compete
off [125I]-MMP-13 except cold MMP-13 [Fig. 3(A)]. In addi-
tion we assessed the speciﬁcity of the receptor binding sys-
tem to MMP-13 by performing binding competition
experiments with a range of cold MMPs. Again the rabbit
chondrocytes were incubated with 5 nM [125I]-MMP-13
and a 100-fold excess of the indicated MMP. Collagenases1 and 2 (MMP-1 and -8) were tested along with stromelysin
(MMP-3) and gelatinase A (MMP-2). MMP-1 did partially
compete for binding with [125I]-MMP-13, however, none of
the other MMPs were able to compete for binding as effec-
tively as cold MMP-13 [Fig. 3(B)].
INTERNALIZATION AND DEGRADATION OF A SINGLE COHORT
OF [125I]-MMP-13 IN RABBIT CHONDROCYTES
By binding [125I]-MMP-13 to the rabbit chondrocytes at
4(C, washing off excess ligand and allowing the cells to be-
come metabolically active at 37(C, it is possible to track the
localization of the ligand within the cells. As demonstrated in
Fig. 6(A) the basal level of [125I]-MMP-13 in the cells was not
zero prior to internalization, which likely indicates the cells
were internalizing MMP-13. Following 20 min at 37(C, there
was a signiﬁcant increase in the amount of radioactivity de-
tected within the cells [Fig. 4(A)], however, there was no
change in the amount of radioactivity released from the
chondrocytes in the form of trichloroacetic acid-soluble deg-
radation products at this early time [Fig. 4(B)]. The internal-
ization of a single cohort of [125I]-MMP-13 was complete by
60 min and the amount of cell-associated radioactivity had
returned to the initial basal level [Fig. 4(A)]. In contrast the
amount of degraded [125I]-MMP-13 released from the cell
as trichloroacetic acid-soluble degradation products in-
creased signiﬁcantly between 30 and 60 min [Fig. 4(B)].
RABBIT CHONDROCYTES EXPRESS LRP1 PROTEIN AND RAP
INHIBITS THE INTERNALIZATION OF THE MMP-13 LIGAND
An immunoblot was performed to determine if the rabbit
chondrocytes express the LRP1 protein. The LRP1 protein
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Fig. 2. Binding kinetics of [125I]-MMP-13 to rabbit chondrocytes. (A)
Conﬂuent chondrocytes were incubated with 5 nM [125I]-MMP-13 for
up to 150 min at 4(C. At the indicated time points the cells were as-
sayed to quantify cell-associated [125I]-MMP-13. Speciﬁc binding (to-
tal - non-speciﬁc) is displayed asmeans S.E.M. for triplicate wells of
a representative experiment. (B) Increasing concentrations of [125I]-
MMP-13 were added to conﬂuent chondrocytes. Non-speciﬁc bind-
ing was assessed by adding a 100-fold excess of MMP-13 to wells
containing [125I]-MMP-13. The cells were incubated at 4(C for 2 h
prior to lysis with 1 M NaOH. Total, speciﬁc binding (total - non-spe-
ciﬁc) and non-speciﬁc binding are displayed as means S.E.M. for
triplicate wells. These data were the mean  S.E.M. of two experi-
ments. (C) Rabbit chondrocytes were incubated in the presence of
5 nM [125I]-MMP-13 and increasing concentrations of cold MMP-13
for 2 h at 4(C. After washing the cells were lysed with 1 M NaOH.
Mean values S.E.M. are plotted for triplicate wells of a representa-
tive experiment. Inset shows a log transformation of the data.is composed of two subunits (515 and 85 kDa) and both
subunits can be clearly seen in the rabbit chondrocytes
and the rat osteoblastic UMR 106-01 cells [Fig. 5(A)]. In or-
der to further characterize the possible involvement of LRP1
in the internalization of [125I]-MMP-13 by rabbit chondro-
cytes, the RAP (LRP1 chaperone protein) was used in an
internalization experiment. RAP competitively binds to
LRP1 and thus prevents the binding of other ligands to
this receptor. Cells not treated with RAP were able to inter-
nalize the MMP-13 protein as previously shown [Figs. 4(A)
and 5(B)], however, in the presence of RAP the rabbit chon-
drocytes were signiﬁcantly impaired in their ability to inter-
nalize [125I]-MMP-13 [Fig. 5(B)]. Similar to previous
observations in both osteoblasts and ﬁbroblasts, there
was no signiﬁcant change in the amount of [125I]-MMP-13
bound to the cell surface of the chondrocytes [Fig. 5(B), in-
set] in the presence of the RAP, however, RAP was able to
inhibit the internalization of MMP-13 in the rabbit chondro-
cytes as we have also seen in osteoblasts and ﬁbroblasts15.
BINDING OF [125I]-MMP-13 TO RABBIT CHONDROCYTES
INDUCES PHOSPHORYLATION OF ERK
The fact that MMP-13 is able to bind to a cell surface re-
ceptor or binding protein raises the possibility that it is also
able to initiate signalling into cells. The LRP1 component of
the MMP-13 internalization system is known to be phos-
phorylated in response to activation of the PDGFR23. To
assess the involvement of MMP-13 in the activation of
the ERK1/2 pathway in chondrocytes, whole cell lysates
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685Osteoarthritis and Cartilage Vol. 14, No. 7from rabbit chondrocytes untreated or treated with MMP-13
were run on an SDS-PAGE gel and immunoblotted with ei-
ther anti P-ERK or anti P-Akt antibodies. As a positive con-
trol, treatment of rabbit chondrocytes with 10 ng/ml of EGF
induced strong phosphorylation of both ERK and Akt
[Fig. 6(A,B)]. Treatment of rabbit chondrocytes with 50 nM
MMP-13 induced phosphorylation of ERK which was
detectable after a 10-min exposure to the enzyme and
was very prominent after 30 and 60 min of MMP-13 treat-
ment [Fig. 6(A)]. However, while EGF induced a strong
phosphorylation of Akt, MMP-13 treatment had no effect
on Akt activation at any of the time points assessed
[Fig. 6(B)]. We have also reported that MMP-13 is able to
bind to the surface and be internalized by other cell types
including osteoblastic cells and ﬁbroblasts. To investigate
if MMP-13 also stimulates phosphorylation of ERK1/2 in
these cells, MEF1 cells were treated with 50 nM MMP-13.
Although MEF1 cells have a higher level of background
ERK phosphorylation than that seen in rabbit chondrocytes,
MMP-13 treatment stimulated phosphorylation of ERK1/2 in
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Fig. 4. Internalization and degradation of a single cohort of [125I]-
MMP-13 in rabbit chondrocytes at 37(C. Cells were incubated at
4(C for 2 h in the presence of 5 nM [125I]-MMP-13. After washing
the cells 3 with cold MEM, 250 ml of warm MEM was added to
each well and the cells were moved to 37(C. At each time point,
the cell media were collected to assess degraded [125I]-MMP-13
(panel B) and the cells were then washed once with MEM. The cells
were treated with 0.25% Pronase for 10 min at 4(C. The cell sus-
pension was collected and centrifuged to separate the cell pellet
shown in panel A (deﬁning internalized [125I]-MMP-13) from the su-
pernatant. Panel B shows the TCA soluble fraction of the superna-
tant (representing the degraded protein). Mean values S.E.M. are
plotted of a representative experiment.MEF1 cells in a similar time course to that observed in the
rabbit chondrocytes. A detectable increase in ERK phos-
phorylation occurred after 20 min MMP-13 treatment and
a greater response occurred after 60 min [Fig. 6(C)].
Interestingly, the observed ERK1/2 phosphorylation seemed
to predominate in chondrocytes compared to ﬁbroblast
cells, possibly suggesting that the MMP-13 receptor system
may produce different biological responses in these two cell
types.
To assess the involvement of LRP1 or the unidentiﬁed
speciﬁc MMP-13 receptor in the phosphorylation of ERK1/
2, chondrocytes were treated with hMMP-1 or mMMP-13
in either the presence or absence of RAP. RAP inhibited
internalization of MMP-13 without altering binding of
mMMP-13 to the cell surface [Fig. 5(B)] or stimulation of
phosphorylation of ERK1/2 [Fig. 6(D)], suggesting that the
speciﬁc MMP-13 receptor is involved in both MMP-13
binding and ERK1/2 activation, however, the LRP1 is only
required for MMP-13 internalization and is not involved in
ERK1/2 phosphorylation.
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Fig. 5. Rabbit chondrocytes express LRP1 and RAP inhibits inter-
nalization of a single cohort of [125I]-MMP-13. (A) Total protein
(10 mg) from rabbit chondrocytes and rat UMR 106-01 osteoblastic
cells were immunoblotted with anti-LRP1 antibodies. (B) Rabbit
chondrocytes were incubated with 5 nM [125I]-MMP-13 in either
the absence (white bars) or the presence (black bars) of RAP. Fol-
lowing incubation the cells were assessed for internalization and
surface bound (inset) radioactive ligand as described in the Mate-
rials and methods. Mean values S.E.M. of triplicate wells are plot-
ted for a representative experiment.
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Fig. 6. Treatment of rabbit chondrocytes or MEF1 cells with MMP-13 results in phosphorylation of ERK1/2 but not Akt and involves the
MMP-13 speciﬁc receptor. Rabbit chondrocytes (A, B and D) or MEF1 cells (C) were serum starved for 24 h, then treated for the indicated
times with or without 50 nM MMP-13, hMMP-1 in the presence or the absence of 5 mM RAP or 10 ng/ml EGF as indicated. Total cell protein
(10 mg) was separated on a 10% SDS-PAGE gel, electrotransferred to PVDF membrane and immunoblotted with either P-ERK1/2 (A, C and
D) or P-Akt (B) antibodies. Following detection the respective blots were stripped and re-probed with ERK1/2 (A, C and D) or Akt (B) antibody
as indicated.Discussion
In this report we characterize the MMP-13 receptor
endocytotic system in rabbit chondrocytes, and identify
that the presence of the enzyme can also inﬂuence phos-
phorylation of intracellular ERK1/2. The presence of this re-
ceptor system has previously been documented in normal
human chondrocytes and shown to be impaired in chondro-
cytes from patients with OA16. While a ready supply of hu-
man chondrocytes from patients with OA can be obtained
from joint replacement surgery, it is difﬁcult to ﬁnd sufﬁcientsamples of normal human articular cartilage. Thus to fully
characterize the MMP-13 endocytotic-receptor system in
chondrocytes we have used rabbit chondrocytes, which
have been extensively used in previous chondrocytic stud-
ies and can be harvested on demand.
The MMP-13 endocytotic-receptor system was ﬁrst iden-
tiﬁed in osteoblastic cells and has subsequently been found
to exist in ﬁbroblasts15, synoviocytes and chondrocytes16.
In the osteoblast and ﬁbroblast this system contains two
components, an unknown high afﬁnity receptor essential
for MMP-13 to bind to the cells, and the low afﬁnity LRP1,
687Osteoarthritis and Cartilage Vol. 14, No. 7which is required for the internalization of MMP-1315. The
present studies in rabbit chondrocytes have also identiﬁed
that there are multiple receptors in the MMP-13 endocy-
totic-receptor system. Similar to the rat osteoblastic and hu-
man chondrocytic studies, the high afﬁnity receptor on
rabbit chondrocytes has a Kd in the nanomolar range
(Kd¼ 5, 13.7 and 12.5 nM, respectively). Similarly the low
afﬁnity receptor identiﬁed on the rabbit chondrocytes had
a dissociation constant of 58.6 nM which is slightly lower,
but comparable to that reported for the human chondro-
cytes, 101 nM. Interestingly, the number of receptors found
on the rat osteoblastic cells and rabbit chondrocytes are
lower than those reported in the human chondrocytes and
this may indicate that this system varies between different
species.
Alternatively, the higher receptor numbers identiﬁed on
the human cells may be reﬂective of the speciﬁcity of the
MMP-13 endocytotic-receptor system which also seems to
vary slightly between species. In the rat osteoblastic cells,
this system was highly speciﬁc with only MMP-13 competing
for binding to the osteoblasts. No speciﬁc binding was iden-
tiﬁed on rat osteoblastic cells when [125I]-MMP-1 and -2 were
used15. In these current studies on rabbit chondrocytes only
MMP-1 was able to compete for binding with [125I]-MMP-13,
but to a lesser extent than MMP-13, while none of the other
collagenases (MMP-8), gelatinase B (MMP-2) or stromely-
sin (MMP-3) competed with MMP-13 for binding, indicating
that this system is very speciﬁc for MMP-13 in rabbit as
well as rodent cells. Interestingly, in the human chondro-
cytes, the MMP-13 endocytotic-receptor system is not com-
pletely speciﬁc for MMP-13, since both MMP-1 and MMP-3
were able to partially compete for binding with [125I]-MMP-
1316. This suggests that the speciﬁcity of this mechanism
varies with different animal species. The increased number
of receptors found on the human cells may reﬂect the fact
that the MMP internalization mechanism endocytoses
MMPs other than MMP-13 in human cells.
Despite the potential difference in the unknown high af-
ﬁnity receptor in the MMP-13 endocytotic-receptor system,
the low afﬁnity receptor previously identiﬁed as LRP115 is
a consistent component of the system for all cells studied.
The LRP1 receptor previously identiﬁed in the osteoblastic
cells and ﬁbroblasts is strongly expressed in the rabbit
chondrocytes and inhibiting its ligand binding functions
with RAP dramatically reduces internalization of MMP-13.
This indicates that the LRP1 component of the MMP-13
endocytotic-receptor system is conserved in rabbits, rodents
and humans.
The observation that external treatment with MMP-13 can
elicit phosphorylation of ERK1/2 is interesting in light of the
effects that activation of this pathway can have on chondro-
cytes. The ERK1/2 signalling pathway has been shown to
be a negative regulator of cartilage-speciﬁc gene expres-
sion in the embryonic limb mesenchyme during chick
development29. ERK1/2 phosphorylation also induces
dedifferentiation of articular chondrocytes grown in mono-
layers30, while down-regulation of ERK1 is required for re-
differentiation of articular chondrocytes31 which indicates
that this signal transduction pathway also has a role in
regulating the adult chondrocyte phenotype. In addition
EGF-induced ERK1/2 phosphorylation is involved in the
regulation of chondrocytic expression of Cox-2 and PGE2
production by the chondrocyte32. PGE2 is a pro-inﬂamma-
tory cytokine found in large quantities in arthritic joints and
has been shown to contribute to joint inﬂammation and
the associated bone erosion33,34. Thus, the ERK1/2 signal-
ling pathway is a pivotal cascade in the chondrocyte and itsactivation prevents maintenance of the chondrocyte pheno-
type and induces the development of a deleterious cytokine
environment. The fact that MMP-13 is increased in OA and
can cause activation of the ERK1/2 pathway suggests that
in addition to regulating the integrity of the extracellular ma-
trix this protease may also regulate the chondrocyte pheno-
type and cytokine production proﬁle through the ERK1/2
pathway in OA.
LRP1 is a member of the LDL receptor superfamily and is
known for its ability to bind and internalize a diverse group
of ligands including proteases35,36, protease inhibitor com-
plexes37,38 and lipoproteins39. Following internalization,
the ligand and LRP1 are uncoupled in cellular endosomes
and the ligands proceed to lysosomes for degradation while
LRP1 is recycled back to the plasma membrane. In addition
to their role in regulating availability of extracellular ligands
the LDL receptor family members can also signal into the
cell. The very low-density lipoprotein receptor and the
apoE receptor are involved in the cortical development
transducing signals mediated by the ligand reelin40,41.
LRP1 has also been implicated in cellular functions other
than ligand internalization, for example the ligand alpha 2
macroglobulin induces calcium inﬂux in neurons when it
binds to LRP142. In addition LRP1 can undergo tyrosine
phosphorylation23 and it has subsequently been shown
that this occurs indirectly through the PDGFR and Src fam-
ily kinases43,44. Despite these observations it was only re-
cently that the importance of LRP1 signalling has been
shown to have physiological signiﬁcance. Boucher et al.23
generated smooth muscle-speciﬁc LRP1 deﬁcient mice
which have an overexpression and subsequent activation
of the PDGFR which results in an increased prevalence of
cholesterol-induced atherosclerosis. Thus in this instance
the presence of LRP1 regulates PDGFR signalling and as
a consequence the cellular response. However, in the
MMP-13 internalization system described here the LRP1
is essential for internalization of the MMP-13 protein but
the process of internalization, and thus LRP1, is not re-
quired for phosphorylation of ERK1/2.
In summary these studies have characterized the MMP-
13 endocytotic-receptor system and identiﬁed some poten-
tial differences between these mechanisms in rabbit, rodent
and human cells. The isolation of the speciﬁc MMP-13
receptor is currently in progress and identiﬁcation of this
receptor will allow for the detailed assessment of the differ-
ences in the rabbit, rodent and human systems as well
as the speciﬁc receptor’s involvement in the MMP-13-stim-
ulated phosphorylation of ERK1/2. The ability of MMP-13 to
activate intracellular ERK1/2 has many consequences for
chondrocytes and further studies are required to elucidate
the physiological and pathological consequences of MMP-
13-induced phosphorylation of ERK1/2 in chondrocytes.
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